• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Tesla, Boeing and Merck Among Companies Hurt by Latest Tariffs

The latest announcement from the U.S. Trade Representative's office is chilling reading for free trade supporters.
By JIM COLLINS
Jun 15, 2018 | 01:04 PM EDT
Stocks quotes in this article: BA, LMT, NOG, UTX, BRK.A, BRK.B, TSLA, GT, CTB, MRK, BMY, JNJ

It's increasingly difficult to separate the noise from the facts when it comes to international trade, especially that between the U.S and China. Friday morning's press release from the Office of the United States Trade Representative breaks out the specifics in much more detail than a presidential tweet. Of the $50 billion of proposed tariffs, $34 billion, representing 1,102 separate product categories, are scheduled to go into effect on July 6th. An additional $16 billion worth (at 2017 trade levels) have been submitted for public comment.

if you believe in free trade the USTR release -- which contains links to the full Section 301 report -- is chilling in its rhetoric. It is clear that the administration is targeting the official Made in China 2025 policy as a means of exposing the Chinese government's pattern of protectionism and promotion of state industries. It's difficult to take the moral high ground on protectionism when imposing tariffs, though, and it seems the trade hawks at the USTR and elsewhere in the administration are hell-bent on undermining their president's greatest foreign policy achievement -- this week's unprecedented sit down with Kim Jong Un.

So, it's difficult to go through 1,100 separate line items, but in the first portion of the tariffs (the $34 billion) there are many references to finished goods and components. The USTR press release makes specific mention of aerospace, information and communications technology, robotics, industrial machinery, new materials, and automobiles.

So, the biggest loser there would be -- as I have pointed out frequently in my RM column including yesterday - Boeing (BA) . I would also add Lockheed Martin (LMT) , Northrop Grumman (NOG) and larger suppliers such as United Technologies (UTX) and Precision Castparts (a subsidiary of Berkshire Hathaway (BRK.A) , (BRK.B) .) In the auto sector, companies that rely heavily on imports from Chinese auto suppliers would be hit hard, but that list really only consists of one: Tesla (TSLA) . I have no idea why Tesla sources so much from mainland Chinese suppliers while the other U.S. manufacturers (both native and captive) depend on local suppliers. Of course, as a general rule, I have no idea why Musk does what he does from a manufacturing perspective, and I probably never will.

The second list of affected goods (the $16 billion that has been proposed with no date set yet for implementation) is heavily represented by engineered chemical compounds, mainly organics. Seeing styrene on the list immediately brought to mind the tiremakers, whose need for synthetic rubber is obviously large, so Goodyear (GT) and Cooper Tire (CTB) would be losers in that aspect.

From a sectoral basis, the largest importer of chemicals into the U.S. is the pharmaceutical industry, so I would include Merck (MRK) , Bristol Myers (BMY) and Johnson and Johnson (JNJ) on a list of companies that would be hit if the second set of tariffs are imposed.

So, that's a long list of names, and really only covers the impacts of U.S. importers. My inclusion of several of the biggest names in the S&P 500 though, should show that the impact of trade troubles is widespread. We will see how China responds to Friday's announcements, which had been telegraphed for the past few weeks, but a tit-for-tat would not be good for equity holders in any geographies. Trade worries could be the anchor that finally stops the S&P 500 from its wildly bullish run.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Collins had no positions in any equities mentioned.

TAGS: Investing | U.S. Equity | Transportation | Consumer Discretionary | Technology | Healthcare | Commodities | Stocks

More from Healthcare

2 Downtrodden Small Biotechs That Are Showing Signs of Life

Bret Jensen
Sep 13, 2019 8:39 AM EDT

T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.

With CVS, Bulls Still Have Their Work Cut Out for Them

Timothy Collins
Sep 12, 2019 12:54 PM EDT

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

Separating Quality Dividend-Paying Companies From the Wannabes: Part 2

Chris Versace
Sep 12, 2019 10:00 AM EDT

We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.

CVS Health Continues to Move Higher - New Stop Recommendation

Bruce Kamich
Sep 12, 2019 9:35 AM EDT

CVS continues to move in the right direction for the bulls.

Planet Fitness Shares May Shed Some Big Weight

Bruce Kamich
Sep 11, 2019 1:15 PM EDT

In the past three years, PLNT bulked up from $20 to $80 and now a major correction to the $50 area -- a 50% correction -- would not be a surprise.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:39 PM EDT CAROLYN BORODEN

    DIA Chart Updated

    Remember the symmetry in the DIA from my article i...
  • 10:54 AM EDT REAL MONEY

    Cramer's '5 Rules for Today's Stock Market'

    Live at 11:45 a.m. ET: Jim Cramer Unveils His '5 R...
  • 09:22 AM EDT PAUL PRICE

    Further Evidence of 'The Turn' Coming Into Effect

    My Real Money Pro column for today detailed the se...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login